Abstract
Omar is a pediatric neurologist with specialist skills in critical care, fetal–neonatal neurology and neurogenetics. His research background includes human genetics and neurosciences as well as developmental neurobiology. He also has significant experience in clinical–translational research specifically related to diseases of the developing brain. Prior to Omar's current role in industry, he designed and implemented novel neurotherapeutic strategies for Rett syndrome and associated autism spectrum disorders, in addition to his clinical and academic responsibilities.
Disclaimer
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Future Medicine Ltd.
Financial & competing interests disclosure
The author is employed by Roche, the sponsor of RG7800 clinical development. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.